Quizartinib

Quizartinib Uses, Dosage, Side Effects, Food Interaction and all others data.

Quizartinib is under investigation in Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies. It is a potent inhibitor of FLT3.

In preclinical studies, Quizartinib demonstrated dose-dependent activity and favorable drug-like profiles in bioavailability, pharmacokinetics, cytochrome P450 (CYP) liability, and absorption, distribution, metabolism, excretion (ADME).

Trade Name Quizartinib
Generic Quizartinib
Quizartinib Other Names Quizartinib, Quizartinibum
Type
Formula C29H32N6O4S
Weight Average: 560.67
Monoisotopic: 560.220574708
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Quizartinib
Quizartinib

How Quizartinib works

Quizartinib potently inhibits FLT3, a kinase that is mutated in approximately one-third of acute myeloid leukemia cases, and patients with FLT3 mutations are less responsive to traditional therapies.

Innovators Monograph

You find simplified version here Quizartinib

*** Taking medicines without doctor's advice can cause long-term problems.
Share